MY-586

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMY-586
Drug Alias NameMY-586
ClassificationVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesThe Second Affiliated Hospital Of Chongqing Medical University
China Registration ClassN/A

Develop Information

Active CompaniesThe Second Affiliated Hospital Of Chongqing Medical University
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A